These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16121812)

  • 1. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
    Lee L; Horowitz J; Frenneaux M
    Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac metabolism in ischemic heart disease.
    Opie LH
    Arch Mal Coeur Vaiss; 1999 Dec; 92(12):1755-60. PubMed ID: 10665328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic intervention for the ischemic and post-ischemic heart.
    Svedjeholm R; Håkanson E; Szabó Z
    Wien Klin Wochenschr; 1999 Jul; 111(13):501-11. PubMed ID: 10444803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological modulation of mitochondrial function during ischemia and reperfusion.
    Monteiro P; Oliveira PJ; Conçalves L; Providência LA
    Rev Port Cardiol; 2003 Mar; 22(3):407-29. PubMed ID: 12847881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of metabolic modulators in ischemic heart disease: an overview.
    Kalra BS; Roy V
    J Clin Pharmacol; 2012 Mar; 52(3):292-305. PubMed ID: 21383339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of cytochrome c on the myocardium during reperfusion].
    Boiarinov GA; Iakovlev AIu; Teziaeva SA; Mukhina IV; Boiarinova LV
    Patol Fiziol Eksp Ter; 1999; (4):20-5. PubMed ID: 10598459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
    Rosano GM; Vitale C; Fragasso G
    Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan cardioprotection reduces the metabolic response during temporary regional coronary occlusion in an open chest pig model.
    Metzsch C; Liao Q; Steen S; Algotsson L
    Acta Anaesthesiol Scand; 2007 Jan; 51(1):86-93. PubMed ID: 17073861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?
    Lopaschuk GD
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S8-11. PubMed ID: 11286307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic support of the ischemic heart during cardiac surgery].
    Luna Ortiz P; Serrano Valdés X; Rojas Pérez E; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S121-36. PubMed ID: 17469340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
    Sack MN; Yellon DM
    J Am Coll Cardiol; 2003 Apr; 41(8):1404-7. PubMed ID: 12706939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved myocardial protection in the failing heart by selective endothelin-A receptor blockade.
    Trescher K; Bauer M; Dietl W; Hallström S; Wick N; Wolfsberger M; Ullrich R; Jürgens G; Wolner E; Podesser BK
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):1005-11, 1011e1. PubMed ID: 19327531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The current aspects of the pharmacological protection of the ischemic myocardium].
    Chichkanov GG
    Eksp Klin Farmakol; 1994; 57(6):15-20. PubMed ID: 7756948
    [No Abstract]   [Full Text] [Related]  

  • 20. A challenge to the metabolic approach to myocardial ischaemia.
    Apstein CS; Opie LH
    Eur Heart J; 2005 May; 26(10):956-9. PubMed ID: 15797886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.